4.4 Article

Disrupting progression of the yeast Hsp90 folding pathway at different transition points results in client-specific maturation defects

期刊

GENETICS
卷 217, 期 3, 页码 -

出版社

OXFORD UNIV PRESS INC
DOI: 10.1093/genetics/iyab009

关键词

molecular chaperone; cochaperone; heat shock factor; tetratricopeptide repeats; Hop/Sti1

资金

  1. National Institute of General Medical Sciences [R01GM127675, R01GM127287]
  2. College of Science at the University of Idaho
  3. NIH [5P30GM103324, P20GM104420]

向作者/读者索取更多资源

Research discovered that certain Hsp90 mutants disrupt the activity of various client proteins, while others affecting client protein activity lead to client-specific effects. These mutants offer new insights into how Hsp90 and co-chaperones identify and interact with different clients.
The protein molecular chaperone Hsp90 (Heat shock protein, 90 kilodalton) plays multiple roles in the biogenesis and regulation of client proteins impacting myriad aspects of cellular physiology. Amino acid alterations located throughout Saccharomyces cerevisiae Hsp90 have been shown to result in reduced client activity and temperature-sensitive growth defects. Although some Hsp90 mutants have been shown to affect activity of particular clients more than others, the mechanistic basis of client-specific effects is unknown. We found that Hsp90 mutants that disrupt the early step of Hsp70 and Sti1 interaction, or show reduced ability to adopt the ATP-bound closed conformation characterized by Sba1 and Cpr6 interaction, similarly disrupt activity of three diverse clients, Utp21, Ssl2, and v-src. In contrast, mutants that appear to alter other steps in the folding pathway had more limited effects on client activity. Protein expression profiling provided additional evidence that mutants that alter similar steps in the folding cycle cause similar in vivo consequences. Our characterization of these mutants provides new insight into how Hsp90 and cochaperones identify and interact with diverse clients, information essential for designing pharmaceutical approaches to selectively inhibit Hsp90 function.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据